Literature DB >> 6791741

Fatal subarachnoid haemorrhage in young women: role of oral contraceptives.

M Thorogood, S A Adam, J I Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6791741      PMCID： PMC1506831          DOI： 10.1136/bmj.283.6294.762

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Mortality in oral contraceptive users.

Authors:  M P Vessey; K McPherson; D Yeates
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

2.  Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

Authors: 
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

3.  Oral contraceptives and fatal subarachnoid haemorrhage.

Authors:  W H Inman
Journal:  Br Med J       Date:  1979-12-08
  3 in total
  6 in total

Review 1.  Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives.

Authors:  P C Hannaford; V Owen-Smith
Journal:  BMJ       Date:  1998-03-28

2.  Cerebral venous thrombosis and subarachnoid haemorrhage in users of oral contraceptives.

Authors:  E Chilvers; P Rudge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

3.  Oral contraceptives and stroke: findings in a large prospective study.

Authors:  M P Vessey; M Lawless; D Yeates
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-01

4.  Oral contraceptives and cardiovascular disease: some questions and answers.

Authors:  M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-27

5.  Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

Authors: 
Journal:  J R Coll Gen Pract       Date:  1983-02

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.